HDAC9 and cancer: A pleiotropic treatment option such as CancerDialysis may make such cancer types more vulnerable towards TCTs, by reducing important cancer characteristics such as increased antioxidative capacity, increased immune suppression, and increased expression of various oncogens of HDAC.